Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachment

Molecular Vision

Volumn 21, Issue , 2015, Pages 417-427

  Dai, Ying ^a   Wu, Zhifeng ^a   Sheng, Huiming ^a   Zhang, Zhengwei ^a   Yu, Mengxi ^a   Zhang, Qing ^a  

^a WUXI NO 2 PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; EOTAXIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MIGRATION INHIBITION FACTOR; PLATELET DERIVED GROWTH FACTOR AA; SOLUBLE INTERCELLULAR ADHESION MOLECULE 1; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG; AUTACOID; BIOLOGICAL MARKER; GROWTH PROMOTOR;

ADULT; AGED; ARTICLE; CALIBRATION; CASE CONTROL STUDY; CHOROID DETACHMENT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOASSAY; MALE; MOLECULAR DYNAMICS; MULTIPLEX BEAD IMMUNOASSAY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETINA DETACHMENT; UPREGULATION; VISUAL ACUITY; VITRECTOMY; VITREORETINOPATHY; CHINA; CHOROID DISEASE; COMPLICATION; METABOLISM; MIDDLE AGED; RETINA TEAR;

ADULT; AGED; BIOMARKERS; CASE-CONTROL STUDIES; CHEMOKINES; CHINA; CHOROID DISEASES; CYTOKINES; FEMALE; GROWTH SUBSTANCES; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; RETINAL DETACHMENT; RETINAL PERFORATIONS; VITREORETINOPATHY, PROLIFERATIVE;

EID: 84927618143     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Jarrett WH 2nd. Rhematogenous retinal detachment complicated by severe intraocular inflammation, hypotony, and choroidal detachment. Trans Am Ophthalmol Soc 1981; 79:664-83. [PMID: 7043870].
2. Zhu J, Xu X, Zhang X. Surgical therapeutic results of rhegmatogenous retinal detachment associated with choroidal detachment. Zhonghua Yan Ke Za Zhi 2002; 38:135-9. [PMID: 11955315].
3. Seelenfreund MH, Kraushar MF, Schepens CL, Freilich DB. Choroidal detachment associated with. Choroidal detachment associated with primary retinal detachment. Arch Ophthalmol 1974; 91:254-8. [PMID: 4621149].
4. Gottlieb F. Combined choroidal and retinal detachment. Arch Ophthalmol 1972; 88:481-6. [PMID: 4634785].
5. Li Z, Li Y, Huang X, Cai XY, Chen X, Li S, Huang Y, Lu L. Quantitative analysis of. Quantitative analysis of rhegmatogenous retinal detachment associated with choroidal detachment in Chinese using UBM. Retina 2012; 32:2020-5. [PMID: 22617830].
6. Sun J, Zhou J, Zhao P, Lian J, Zhu H, Zhou Y, Sun Y, Wang Y, Zhao L, Wei Y, Wang L, Cun B, Ge S, Fan X. High prevalence of myopia and high myopia in 5060 Chinese university students in Shanghai. Invest Ophthalmol Vis Sci 2012; 53:7504-9. [PMID: 23060137].
7. Kang JH, Park KA, Shin WJ, Kang SW. Macular Macular hole as a risk factor of choroidal detachment in rhegmatogenous retinal detachment KJO 2008; 22:100-3. [PMID: 18612227].
8. Gui JM, Jia L, Liu L, Liu JD. Vitrectomy, lensectomy and silicone oil tamponade in the management of retinal detachment associated with choroidal detachment. International Journal of Ophthalmology. 2013; 6:337-41. [PMID: 23826529].
9. Ghoraba HH. Primary vitrectomy for the management of rhegmatogenous retinal detachment associated with choroidal detachment Albrecht Von Graefes Arch Klin Exp Ophthalmol 2001; 239:733-6. [PMID: 11760032].
10. Sharma T, Gopal L, Badrinath SS. Primary vitrectomy for rhegmatogenous retinal detachment associated with choroidal detachment. Ophthalmology 1998; 105:2282-5. [PMID: 9855161].
11. Sharma T, Gopal L, Reddy RK, Kasinathan N, Shah NA, Sulochana KN, Miriam KC, Arvind K, Ramakrishnan S, Sukumar B. Primary vitrectomy for combined rhegmatogenous retinal detachment and choroidal detachment with or without oral corticosteroids: a pilot study. Retina 2005; 25:152-7. [PMID: 15689804].
12. Wei Y, Wang N, Chen F, Wang H, Bi C, Zu Z, Yang X. Vitrectomy combined with periocular/intravitreal injection of steroids for rhegmatogenous retinal detachment associated with choroidal detachment. Retina 2014; 34:136-41. [PMID: 23648998].
13. Nakazawa T, Matsubara A, Noda K, Hisatomi T, She H, Skondra D, Miyahara S, Sobrin L, Thomas KL, Chen DF, Grosskreutz CL, Hafezi-Moghadam A, Miller JW. Characterization of cytokine responses to retinal detachment in rats. Mol Vis 2006; 12:867-78. [PMID: 16917487].
14. Banerjee S, Savant V, Scott RA, Curnow SJ, Wallace GR, Murray PI. Multiplex bead analysis of. Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders. Invest Ophthalmol Vis Sci 2007; 48:2203-7. [PMID: 17460280].
15. Yoshimura T, Sonoda KH, Sugahara M, Mochizuki Y, Enaida H, Oshima Y, Ueno A, Hata Y, Yoshida H, Ishibashi T. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS ONE 2009; 4:e8158-[PMID: 19997642].
16. Oppenheim JJ. Cytokines: past, present, and future. Int J Hematol 2001; 74:3-8. [PMID: 11530802].
17. Vilcek J, Feldmann M. Historical review: Cytokines as therapeutics and targets of therapeutics. Trends Pharmacol Sci 2004; 25:201-9. [PMID: 15063084].
18. Struyf S, Proost P, Van Damme J. Regulation of the immune response by the interaction of chemokines and proteases. Adv Immunol 2003; 81:1-44. [PMID: 14711052].
19. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983; 90:121-5. [PMID: 6856248].
20. Kapin MA, Yanni JM, Brady MT, McDonough TJ, Flanagan JG, Rawji MH, Dahlin DC, Sanders ME, Gamache DA. Inflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenac. Inflammation 2003; 27:281-91. [PMID: 14635785].
21. Ricker LJ, Kessels AG, de Jager W, Hendrikse F, Kijlstra A, la Heij EC. Prediction of proliferative vitreoretinopathy after retinal detachment surgery: potential of biomarker profiling. Am J Ophthalmol 2012; 154:347-54. [PMID: 22541653].
22. Ricker LJ, Altara R, Goezinne F, Hendrikse F, Kijlstra A, La Heij EC. Soluble apoptotic factors and. Soluble apoptotic factors and adhesion molecules in rhegmatogenous retinal detachment. Invest Ophthalmol Vis Sci 2011; 52:4256-62. [PMID: 21372012].
23. Ricker LJ, Kijlstra A, de Jager W, Liem AT, Hendrikse F, La Heij EC. Chemokine levels in. Chemokine levels in subretinal fluid obtained during scleral buckling surgery after rhegmatogenous retinal detachment. Invest Ophthalmol Vis Sci 2010; 51:4143-50. [PMID: 20335622].
24. Yogo Y, Fujishima S, Inoue T, Saito F, Shiomi T, Yamaguchi K, Ishizaka A. Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis. Respir Res 2009; 10:80-[PMID: 19715610].
25. Bromberg-White JL, Glazer L, Downer R, Furge K, Boguslawski E, Duesbery NS. Identification of VEGF-independent cytokines in proliferative diabetic retinopathy vitreous. Invest Ophthalmol Vis Sci 2013; 54:6472-80. [PMID: 24003089].
26. Singh A, Leng L, Fan J, Gajda M, Brauer R, Fingerle-Rowson G, Bucala R, Illges H. Macrophage-derived, macrophage migration inhibitory factor (MIF) is necessary to induce disease in the K/BxN serum-induced model of arthritis. Rheumatol Int 2013; 33:2301-8. [PMID: 23503937].
27. Choi M, Lee M, Rhim T. Dexamethasone-conjugated polyethylenimine/MIF siRNA complex regulation of particulate matter-induced airway inflammation. Biomaterials 2013; 34:7453-61. [PMID: 23831186].
28. Takase H, Sugita S, Rhee DJ, Imai Y, Taguchi C, Sugamoto Y, Tagawa Y, Nishihira J, Russell P, Mochizuki M. The presence of macrophage migration inhibitory factor in human trabecular meshwork and its upregulatory effects on the T helper 1 cytokine. Invest Ophthalmol Vis Sci 2002; 43:2691-6. [PMID: 12147604].
29. Matsuda A, Tagawa Y, Matsuda H, Nishihira J. Identification and immunohistochemical localization of macrophage migration inhibitory factor in human cornea. FEBS Lett 1996; 385:225-8. [PMID: 8647256].
30. Wen Y, Li GW, Bekhor I. Lens epithelial cell mRNA. III. Elevated expression of macrophage migration inhibitory factor mRNA in galactose cataracts. Curr Eye Res 1996; 15:125-30. [PMID: 8670719].
31. Taguchi C, Sugita S, Tagawa Y, Nishihira J, Mochizuki M. Macrophage migration inhibitory factor in ocular fluids of patients with uveitis. Br J Ophthalmol 2001; 85:1367-71. [PMID: 11673308].
32. Limb GA, Chignell AH. Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy. Br J Ophthalmol 1999; 83:953-6. [PMID: 10413701].
33. Leeuwenberg JF, Smeets EF, Neefjes JJ, Shaffer MA, Cinek T, Jeunhomme TM, Ahern TJ, Buurman WAE. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 1992; 77:543-9. [PMID: 1283598].
34. Platts KE, Benson MT, Rennie IG, Sharrard RM, Rees RC. Cytokine modulation of adhesion molecule expression on human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1995; 36:2262-9. [PMID: 7558720].
35. Webster L, Stanbury RM, Chignell AH, Limb GA. Vitreous intercellular adhesion molecule 1 in uveitis complicated by retinal detachment. Br J Ophthalmol 1998; 82:438-43. [PMID: 9640197].
36. Limb GA, Hickman-Casey J, Hollifield RD, Chignell AH. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1999; 40:2453-7. [PMID: 10476819].
37. Limb GA, Chignell AH, Cole CJ, Green WT, Webster L, Hollifield RD, Dumonde DC. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1997; 38:1043-8. [PMID: 9113001].
38. Park SP, Ahn JK. Changes of aqueous vascular endothelial growth factor and interleukin-6 after intravitreal triamcinolone for branch retinal vein occlusion. Clin Experiment Ophthalmol 2008; 36:831-5. [PMID: 19278477].
39. Arimura N, Otsuka H, Yamakiri K, Sonoda Y, Nakao S, Noda Y, Hashiguchi T, Maruyama I, Sakamoto T. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy. Ophthalmology 2009; 116:921-6. [PMID: 19410951].
40. Yilmaz T, Weaver CD, Gallagher MJ, Cordero-Coma M, Cervantes-Castaneda RA, Klisovic D, Lavaque AJ, Larson RJ. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review. Ophthalmology 2009; 116:902-11., quiz 12–3. [PMID: 19410949].
41. Wickham L, Bunce C, Wong D, McGurn D, Charteris DG. Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy. Ophthalmology 2007; 114:698-704. [PMID: 17398320].
42. Ahmadieh H, Feghhi M, Tabatabaei H, Shoeibi N, Ramezani A, Mohebbi MR. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial. Ophthalmology 2008; 115:1938-43. [PMID: 18584876].
43. Li C, Wang J, Wilson PB, Kumar P, Levine E, Hunter RD, Kumar S. Role of transforming growth factor beta3 in lymphatic metastasis in breast cancer. Int J Cancer 1998; 79:455-9. [PMID: 9761112].
44. Lutty GA, Merges C, Threlkeld AB, Crone S, McLeod DS. Heterogeneity in localization of isoforms of TGF-beta in human retina, vitreous, and choroid. Invest Ophthalmol Vis Sci 1993; 34:477-87. [PMID: 7680639].
45. Kapral M, Wawszczyk J, Sosnicki S, Weglarz L. Differential influence of inositol hexaphosphate on the expression of genes encoding TGF-beta isoforms and their receptors in intestinal epithelial cells stimulated with proinflammatory agents. Mediators Inflamm 2013; 2013:436894-[PMID: 24459329].
46. Li G, Fox J 3rd, Liu Z, Liu J, Gao GF, Jin Y, Gao H, Wu M. Lyn mitigates mouse airway remodeling. Lyn mitigates mouse airway remodeling by downregulating the TGF-beta3 isoform in house dust mite models. J Immunol 2013; 191:5359-70. [PMID: 24127553].
47. Chang Z, Kishimoto Y, Hasan A, Welham NV. TGF-beta3 modulates the inflammatory environment and reduces scar formation following vocal fold mucosal injury in rats. Dis Model Mech 2014; 7:83-91. [PMID: 24092879].
48. Ricker LJ, Kijlstra A, Kessels AG, de jager W, Liem AT, Hendrikse F, La Heij EC. Interleukin and growth factor levels in subretinal fluid in rhegmatogenous retinal detachment: a case-control study. PLoS ONE 2011; 6:e19141-[PMID: 21556354].
49. Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Eur Cytokine Netw 2006; 17:155-65. [PMID: 17194635].
50. Wallace GR, John Curnow S, Wloka K, Salmon M, Murray PI. The role of chemokines and their receptors in ocular disease. Prog Retin Eye Res 2004; 23:435-48. [PMID: 15219876].
51. Falk MK, Singh A, Faber C, Nissen MH, Hviid T, Sorensen T. Blood expression levels of chemokine receptor CCR3 and chemokine CCL11 in age-related macular degeneration: a case-control study. BMC Ophthalmol 2014; 14:22-[PMID: 24575855].
52. Hooks JJ, Nagineni CN, Hooper LC, Hayashi K, Detrick B. IFN-beta provides immuno-protection in the retina by inhibiting ICAM-1 and CXCL9 in retinal pigment epithelial cells. J Immunol 2008; 180:3789-96. [PMID: 18322185].
53. Chen J, Vistica BP, Takase H, Ham DI, Fariss RN, Wawrousek EF, Chan CC, Demartino JA, Farber JM, Gery I. A unique pattern of up- and down-regulation of chemokine receptor CXCR3 on inflammation-inducing Th1 cells. Eur J Immunol 2004; 34:2885-94. [PMID: 15368305].
54. Imai T, Nagira M, Takagi S, Kakizaki M, Nishimura M, Wang J, Gray PW, Matsushima K, Yoshie O. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999; 11:81-8. [PMID: 10050676].
55. Kang S, Xie J, Ma S, Liao W, Zhang J, Luo R. Targeted knock down of CCL22 and CCL17 by siRNA during DC differentiation and maturation affects the recruitment of T subsets. Immunobiology 2010; 215:153-62. [PMID: 19450895].
56. Förster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008; 8:362-71. [PMID: 18379575].